Response to Comments: MolDX Pigmented Lesion Assay

This document (A58072) is a response to comments on the MolDX: Pigmented Lesion Assay LCD (L38151). It records the comment period (May 30–July 14, 2019), the notice period start (April 23, 2020), and the LCD effective date (June 7, 2020). No clinical coverage criteria, limitations, or frequency rules are specified in this response document.

"This document is a response to provider comments on the MolDX: Pigmented Lesion Assay Local Coverage Determination (LCD L38151)."

Sign up to see full coverage criteria, indications, and limitations.